An interventional study of Mindfulness-Based Psychoeducation in SCHIZOPHRENIA 1 (Disorder), Mindfulness and Insight, sponsored by Dicle University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Dicle University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 96 studies in Schizophrenia with a site in Turkey — 19 open to participants now, 20 under way, none of them phase 3. Schizophrenia · Turkey.
Among the 96 studies in Schizophrenia with a site in Turkey, this one is the 33rd largest by enrollment of the 81 interventional ones that give a count, is one of 17 that started in 2025, is one of 57 with no phase, and was the 93rd registered.
3,574 studies on the registry are indexed under Schizophrenia; 496 are open to participants now.
Browse Schizophrenia studies →19 of the 96 studies in Schizophrenia with a site in Turkey are open now. Recruiting first, the newest first:
Abant Izzet Baysal University · Sites in Turkey
Ages 18–65
Firat University · Sites in Turkey
Ages 18–60 · Healthy volunteers
Abant Izzet Baysal University · Sites in Turkey
Ages 18–65
Medipol University · Sites in Turkey
Ages 18–65
Çankırı Karatekin University · Sites in Turkey
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 334 Schizophrenia studies recruiting now, 63 (19%) set no upper age limit and 259 (78%) stop at 75 or younger; 42 take children under 18; 83 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
96 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 17 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 66 is close to the median of 70 across 2,953 interventional studies indexed under Schizophrenia.
Median enrollment 60 across the 81 interventional studies, 90 across the 15 observational. Of the 73 that completed or were terminated, 14 (19%) have results posted.
This tab as a report to print or save as PDF → With an account.
28 of 96 have an industry lead sponsor. The 10 most frequent:
Dicle University is the lead sponsor of 29 studies on the registry; 7 are open to participants now.
Dicle University has 1 study filed under Schizophrenia — fewer than ten, so there is no comparison to draw.
4 of the studies in Schizophrenia with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07534475Medipol UniversityVenous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT | 2026-11-30 |
| NCT07898852Dokuz Eylul UniversityIntegrated Psychoeducation Program for Internalized Stigma in Schizophrenia | 2026-12-25 |
| NCT07656558Aydin Adnan Menderes UniversityACT-Based Psychoeducation for Caregivers of Patients With Schizophrenia | 2026-12-30 |
| NCT06971328Ataturk UniversityACT-Based Psychoeducation for Schizophrenia Caregivers | 2027-01-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 96 studies in Schizophrenia with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
**Detailed Description**
Schizophrenia is a chronic psychiatric disorder associated with disturbances in thought, perception, emotion, and behavior that can substantially affect psychosocial functioning and recovery. Psychological resilience and insight are important components of recovery-oriented care in individuals diagnosed with schizophrenia. Psychological resilience refers to the ability to adapt to stressful experiences and recover from adversity, whereas insight involves awareness of the illness, recognition of psychiatric symptoms, and understanding of the need for treatment. Psychosocial interventions targeting these dimensions may complement routine pharmacological treatment.
Mindfulness-based psychoeducation combines structured educational activities with mindfulness practices that emphasize present-moment awareness, non-judgmental acceptance, and adaptive responses to psychological experiences. This approach aims to strengthen coping strategies, promote awareness of illness-related experiences, and support engagement in psychiatric treatment. The present study was designed to evaluate the effects of mindfulness-based psychoeducation on psychological resilience and insight among individuals diagnosed with schizophrenia.
**Study Design and Setting**
This study employed a randomized controlled pretest-posttest design and was conducted between January and December 2025 at a Community Mental Health Center (CMHC) affiliated with a research and training hospital in Türkiye. The center provides community-based psychiatric treatment, rehabilitation, psychoeducation, individual counseling, group therapy, and psychosocial support to individuals with severe mental disorders.
Participants were individuals diagnosed with schizophrenia who were receiving regular psychiatric follow-up and antipsychotic treatment at the CMHC. Participants were clinically stable and in remission at enrollment. Routine psychiatric treatment and follow-up continued throughout the study, and no medication modifications were introduced as part of the research protocol.
Participants were assigned to intervention and control groups using computer-generated block randomization with a block size of four. Because of the nature of the psychoeducational intervention, blinding of participants and researchers was not feasible. Data obtained from the intervention and control groups were coded before statistical analysis to reduce potential assessment bias.
**Mindfulness-Based Psychoeducation Intervention**
The intervention consisted of a structured mindfulness-based psychoeducation program adapted from mindfulness-based stress reduction (MBSR) principles and relevant psychoeducational approaches.
Before the intervention, a preparatory session was conducted to introduce participants to the program and complete baseline assessments. The intervention subsequently consisted of eight weekly group sessions, each lasting approximately 45-50 minutes.
The intervention was delivered face-to-face by a researcher who had previously completed MBSR training. Participants in the intervention group were organized into four smaller groups of approximately eight or nine individuals. Sessions were conducted in a separate, quiet meeting room at the CMHC to provide an appropriate environment for mindfulness practices and minimize potential contamination between study groups.
The program integrated mindfulness practices and psychoeducational activities intended to promote present-moment awareness, non-judgmental observation of internal experiences, psychological adaptation, and illness awareness. Participants were assigned practice-related homework following each session to encourage the application of the techniques outside the group setting. Make-up sessions were arranged when necessary to support continuity of participation.
The control group did not receive the mindfulness-based psychoeducation intervention. Participants in both groups continued to receive routine psychiatric care and follow-up services provided by the CMHC.
**Outcome Assessment**
Psychological resilience and insight were assessed before and after the intervention using the Brief Resilience Scale (BRS) and the Birchwood Insight Scale (BIS), respectively. Sociodemographic and clinical characteristics were collected using a Descriptive Characteristics Form.
The BRS was used to assess participants' perceived ability to recover from stressful experiences, whereas the BIS was used to evaluate illness awareness, recognition of symptoms, and awareness of the need for treatment.
**Safety Monitoring**
Participants were monitored throughout the study for potential adverse events associated with mindfulness-based psychoeducation. Safety monitoring included physical discomfort, dizziness, falls, deterioration in psychiatric symptoms, hospital admissions, and other potential intervention-related concerns.
Participants' clinical conditions were routinely followed by healthcare professionals at the CMHC, including psychiatrists, psychologists, and nurses. Any adverse events or safety concerns reported by participants were documented and evaluated by the research team.
**Ethical Considerations**
The study received approval from a university ethics committee (Approval No: 2024/717838), and institutional permission was obtained from the CMHC. All participants were informed about the purpose and procedures of the study, confidentiality of their information, and their right to withdraw at any time. Written informed consent was obtained before participation. The study was conducted in accordance with the principles of the Declaration of Helsinki.
3,574 studies on the registry are indexed under Schizophrenia; 496 are open to participants now.
This study's enrollment of 66 is close to the median of 70 across 2,953 interventional studies indexed under Schizophrenia.
Browse Schizophrenia studies →Dicle University is the lead sponsor of 29 studies on the registry; 7 are open to participants now.
Compared within Schizophrenia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Inclusion Criteria: • Being open to communication and collaboration,
Exclusion Criteria:
Being in acute exacerbation period (the period when the positive symptoms of the illness are intense)
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Inclusion Criteria * Being open to communication and collaboration, * Being 18 years and above, * Being diagnosed with schizophrenia (The individuals participating in the study were diagnosed with schizophrenia by a psychiatrist according to DSM-5 criteria) * Regularly attending at CMHC (at least 2 days per a week) * Being at least primary school degree Exclusion Criteria * Being in acute exacerbation period (the period when the positive symptoms of the illness are intense) * Having comorbid mental illness identified by CMHC records * Having dementia or any other organic mental disorder identified by CMHC records * Having intellectual disability identified by CMHC records
Other: Mindfulness-Based Psychoeducation
No intervention
Nursing Intervention An adapted mindfulness-based psychoeducation program informed by MBSR principles. The Mindfulness-based psychoeducation was carried out for the experimental group. The researcher implementing the mindfulness-based psychoeducation completed the MBSR program led by MBSR instructor Prof. Dr. Aysel KARACA (Accreditation No: TTI-01202001) between May 27 and July 15, 2021, and earned a certificate of participation. The training was carried out by the researcher in the meeting room at CMHC. The experimental group was divided into four groups, each containing eight or nine participants. The researcher provided face-to-face and group training once a week for eight weeks (Except for the week when the preparatory session is held). Each session was 45-50 minutes on average. In addition, make-up sessions were held for individuals who could not attend the original sessions (Thanks to the same topic being presented across four different sessions within a single week, the individu
Change From Baseline in Brief Resilience Scale (BRS) Total Score
Psychological resilience was assessed using the Brief Resilience Scale (BRS), a six-item self-report instrument designed to measure the ability to recover from stressful experiences. Each item is rated on a five-point Likert scale ranging from 1 to 5. Items 2, 4, and 6 are reverse-scored. The scores of all six items are summed to obtain a single total score ranging from 6 to 30 points, with higher scores indicating greater psychological resilience. The outcome was evaluated by comparing the BRS total scores obtained during the preparatory session (baseline assessment) and the eighth intervention session (post-test assessment).
Time frame: Baseline (before intervention) and week 8 (immediately after completion of the intervention)
Change From Baseline in Birchwood Insight Scale (BIS) Total Score
Illness insight was assessed using the Birchwood Insight Scale (BIS), an eight-item self-report instrument evaluating awareness of illness, recognition of symptoms, and awareness of the need for treatment. Each item is scored from 0 to 2. The scores from items 1, 2, 7, and 8 are summed directly, while the sum of items 3, 4, 5, and 6 is divided by two and added to the total score. These item scores are combined to obtain a single BIS total score ranging from 0 to 12 points, with higher scores indicating greater insight. The outcome was evaluated by comparing the BIS total scores obtained during the preparatory session (baseline assessment) and the eighth intervention session (post-test assessment).
Time frame: Baseline (before intervention) and week 8 (immediately after completion of the intervention)
Plan to share: Yes
Supporting information: Study protocol
No publications or documents are linked to this record.
Ran from Jan 2025 to primary completion in Dec 2025, 11 months.
Of 762 non-industry interventional studies with no phase under Schizophrenia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 56. This study's 11 months is below that.
Counting every sponsor, half of 775 studies reached it within 32 months; a quarter within 16 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dicle University